Candida albicans is an opportunistic human fungal pathogen that causes life-threatening systemic infections, as well as oral mucosal infections. Phospholipids are crucial for pathogenesis in C. albicans, as disruption of phosphatidylserine (PS) and phosphatidylethanolamine (PE) biosynthesis within the cytidine diphosphate diacylglycerol (CDP-DAG) pathway causes avirulence in a mouse model of systemic infection. The synthesis of PE by this pathway plays a crucial role in virulence, but it was unknown if downstream conversion of PE to phosphatidylcholine (PC) is required for pathogenicity. Therefore, the enzymes responsible for methylating PE to PC, Pem1 and Pem2, were disrupted. The resulting pem1Δ/Δ pem2Δ/Δ mutant was not less virulent in m...
Candida albicans mutants for phosphatidylserine (PS) synthase (cho1ΔΔ) and PS decarboxylase (psd1ΔΔ ...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
Candida albicans is an opportunistic human fungal pathogen that causes life-threatening systemic inf...
Candida albicans is an opportunistic human fungal pathogen that causes life-threatening systemic inf...
Human fungal pathogens, which cause approximately two million life-threatening infections annually, ...
This work was supported by the National Institutes of Health NIH R01AL105690.Phosphatidylserine (PS)...
Phosphatidylserine (PS) synthase (Cho1p) and the PS decarboxylase enzymes (Psd1p and Psd2p), which s...
The phospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE) play important roles in ...
Candida albicans mutants for phosphatidylserine (PS) synthase (cho1ΔΔ) and PS decarboxylase (psd1ΔΔ ...
Candida albicans occupies diverse ecological niches within the host and must tolerate a wide range o...
Candida albicans occupies diverse ecological niches within the host and must tolerate a wide range o...
In hospitalized patients with neutropenia, Candida albicans is the fourth leading cause of systemic ...
Candida albicans occupies diverse ecological niches within the host and must tolerate a wide range o...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
Candida albicans mutants for phosphatidylserine (PS) synthase (cho1ΔΔ) and PS decarboxylase (psd1ΔΔ ...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
Candida albicans is an opportunistic human fungal pathogen that causes life-threatening systemic inf...
Candida albicans is an opportunistic human fungal pathogen that causes life-threatening systemic inf...
Human fungal pathogens, which cause approximately two million life-threatening infections annually, ...
This work was supported by the National Institutes of Health NIH R01AL105690.Phosphatidylserine (PS)...
Phosphatidylserine (PS) synthase (Cho1p) and the PS decarboxylase enzymes (Psd1p and Psd2p), which s...
The phospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE) play important roles in ...
Candida albicans mutants for phosphatidylserine (PS) synthase (cho1ΔΔ) and PS decarboxylase (psd1ΔΔ ...
Candida albicans occupies diverse ecological niches within the host and must tolerate a wide range o...
Candida albicans occupies diverse ecological niches within the host and must tolerate a wide range o...
In hospitalized patients with neutropenia, Candida albicans is the fourth leading cause of systemic ...
Candida albicans occupies diverse ecological niches within the host and must tolerate a wide range o...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
Candida albicans mutants for phosphatidylserine (PS) synthase (cho1ΔΔ) and PS decarboxylase (psd1ΔΔ ...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...
<p>Antifungal agents for the treatment of Candida albicans infections are limited. We recently disco...